Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials.
By Funda Meric-Bernstam, Lauren Brusco, K. Shaw, Chacha Horombe, S. Kopetz, M. Davies, M. Routbort, S. Piha-Paul, F. Janku, N. Ueno and 9 more. 2015
375 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Syuzo Kaneko
- Masaaki Komatsu
- Ken Asada
- Ken Takasawa
- Ryuji Hamamoto
- Yusuke Nakamura
- N. Dohmae
- Takehiro Suzuki
Citations in the corpus
- Molecular profiling for precision cancer therapies (2020, neutral): “MDACC [26] 2000 11–50 gene panels FFPE No 83/2000 (4.”
- Epigenetics Analysis and Integrated Analysis of Multiomics Data, Including Epigenetic Data, Using Artificial Intelligence in the Era of Precision Medicine (2019, methodology): “According to the data about matching plans of the National Cancer Institute, only 2% people can benefit from targeted drugs [4,6].”
- Extracting Biological Insights from the Project Achilles Genome-Scale CRISPR Screens in Cancer Cell Lines (2019, methodology): “In the interim, in cases where cell lines have copy number (CN) calls from multiple sources, we use the following priority rules: (1) Broad WES-based CN calls are always used if available.”